Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540 · see citing works

Assessing Self‐maintenance: Activities of Daily Living, Mobility, and Instrumental Activities of Daily Living

Katz, S. (1983) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1983.tb03391.x · Cited by 2,734 · see citing works

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · see citing works

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296 · see citing works

Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease

Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · see citing works

An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease

Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531 · see citing works

Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro

Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08858.x · Cited by 463 · see citing works

The Role of Oxidative Stress in Alzheimer Disease

Markesbery, W. R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.12.1449 · Cited by 307 · see citing works

N-acetyl-l-cysteine

de Vries, N., & Flora, S. D. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240531040 · Cited by 274 · see citing works

The role of oxidative stress in neurodegenerative diseases

Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355 · see citing works

The chemistry and biological activities of N-acetylcysteine

Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.016 · Cited by 876 · see citing works

Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits

Rushworth, G. F., & Megson, I. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.006 · Cited by 724 · see citing works

N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency

Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.005 · Cited by 721 · see citing works

Bioinorganic Chemistry of Alzheimer’s Disease

Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672 · see citing works

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · see citing works

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500 · see citing works

<i>N</i>-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Dean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100057 · Cited by 494 · see citing works

Oxidative stress and aberrant signaling in aging and cognitive decline

Dröge, W., & Schipper, H. M. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00294.x · Cited by 479 · see citing works

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463 · see citing works

Modification of Brain Aging and Neurodegenerative Disorders by Genes, Diet, and Behavior

Mattson, M. P., Chan, S. L., & Duan, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00004.2002 · Cited by 438 · see citing works

The promise of N-acetylcysteine in neuropsychiatry

Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434 · see citing works

<i>N</i> -acetylcysteine for antioxidant therapy: pharmacology and clinical utility

Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14728220802517901 · Cited by 413 · see citing works

N‐acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities

Shahripour, R. B., Harrigan, M. R., & Alexandrov, A. V. (2014) · Brain and Behavior · doi:10.1002/brb3.208 · Cited by 412 · see citing works

ESPEN guidelines on nutrition in dementia

Volkert, D., Chourdakis, M., Faxen-Irving, G., Frühwald, T., Landi, F., Suominen, M. H., Vandewoude, M., Wirth, R., & Schneider, S. M. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.09.004 · Cited by 442 · see citing works

Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases

Johnson, W. M., Wilson‐Delfosse, A. L., & Mieyal, J. J. (2012) · Nutrients · doi:10.3390/nu4101399 · Cited by 354 · see citing works

Elevation of Glutathione as a Therapeutic Strategy in Alzheimer Disease

Pocernich, C., & Butterfield, D. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2011.10.003 · Cited by 333 · see citing works

The essential elements of Alzheimer’s disease

Lei, P., Ayton, S., & Bush, A. I. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.008207 · Cited by 336 · see citing works

Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications

Apostolova, N., & Víctor, V. M. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5952 · Cited by 303 · see citing works

N‐acetylcysteine targets 5 lipoxygenase‐derived, toxic lipids and can synergize with prostaglandin E 2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice

Karuppagounder, S. S., Alin, L., Chen, Y., Brand, D. D., Bourassa, M. W., Dietrich, K., Wilkinson, C. M., Nadeau, C. A., Kumar, A., Perry, S., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25356 · Cited by 294 · see citing works

The ongoing pursuit of neuroprotective therapies in Parkinson disease

Athauda, D. S., & Foltynie, T. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.226 · Cited by 267 · see citing works

The Glutamatergic System and Alzheimer???s Disease

Butterfield, D. A., & Pocernich, C. B. (2003) · CNS Drugs · doi:10.2165/00023210-200317090-00004 · Cited by 267 · see citing works

Cognitive remission: a novel objective for the treatment of major depression?

Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252 · see citing works

Antioxidants as treatment for neurodegenerative disorders

Moosmann, B., & Behl, C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1407 · Cited by 253 · see citing works

“Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials”

Donoso, A., González-Durán, J., Agurto-Muñoz, A., González, P. A., & Agurto-Muñoz, C. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105479 · Cited by 246 · see citing works

Antioxidants in Central Nervous System Diseases: Preclinical Promise and Translational Challenges

Kamat, C. D., Gadal, S., Mhatre, M., Williamson, K. S., Pye, Q. N., & Hensley, K. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15314 · Cited by 237 · see citing works

Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist

Nicolakakis, N., Aboulkassim, T., Ongali, B., Lecrux, C., Fernandes, P., Rosa-Neto, P., Tong, X.-K., & Hamel, E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3348-08.2008 · Cited by 262 · see citing works

Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects

Wojsiat, J., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6435861 · Cited by 221 · see citing works

Neuronal Apoptosis in Neurodegeneration

Okouchi, M., Ekshyyan, O. Y., Maracine, M., & Aw, T. Y. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1511 · Cited by 219 · see citing works

Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants

Dröge, W. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00175-4 · Cited by 217 · see citing works

N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases

Holmay, M. J., Terpstra, M., Coles, L. D., Mishra, U., Ahlskog, M., Öz, G., Cloyd, J. C., & Tuite, P. J. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31829ae713 · Cited by 216 · see citing works

Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease

Jakaria, M., Belaidi, A. A., Bush, A. I., & Ayton, S. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15519 · Cited by 212 · see citing works

Neurotoxicity of MAO Metabolites of Catecholamine Neurotransmitters: Role in Neurodegenerative Diseases

Burke, W. J. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00090-1 · Cited by 210 · see citing works

Thinking Outside the Cleft to Understand Synaptic Activity: Contribution of the Cystine-Glutamate Antiporter (System xc−) to Normal and Pathological Glutamatergic Signaling

Bridges, R., Lutgen, V., Lobner, D., & Baker, D. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003889 · Cited by 205 · see citing works

Lipoic Acid and N-acetyl Cysteine Decrease Mitochondrial-Related Oxidative Stress in Alzheimer Disease Patient Fibroblasts

Moreira, P. I., Harris, P. L. R., Zhu, X., Santos, M. S., Oliveira, C. R., Smith, M. A., & Perry, G. L. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12210 · Cited by 197 · see citing works

The influence of common free radicals and antioxidants on development of Alzheimer’s Disease

Wojtunik‐Kulesza, K. A., Oniszczuk, A., Oniszczuk, T., & Waksmundzka‐Hajnos, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.024 · Cited by 195 · see citing works

Safety and Tolerability of N‐Acetylcysteine in Cocaine‐Dependent Individuals

LaRowe, S. D., Mardikian, P. N., Malcolm, R. J., Myrick, H., Kalivas, P. W., McFarland, K., Saladin, M. E., McRae‐Clark, A. L., & Brady, K. T. (2006) · American Journal on Addictions · doi:10.1080/10550490500419169 · Cited by 181 · see citing works

Cognitive dysfunction with aging and the role of inflammation

Simen, A. A., Bordner, K. A., Martin, M. P., Moy, L. A., & Barry, L. C. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311399145 · Cited by 174 · see citing works

Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats

Lomeli, N., Di, K., Czerniawski, J. L., Guzowski, J. F., & Bota, D. A. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.046 · Cited by 173 · see citing works

Cerebral Iron Deposition in Neurodegeneration

Dušek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 159 · see citing works

Glutathione in Brain: Overview of Its Conformations, Functions, Biochemical Characteristics, Quantitation and Potential Therapeutic Role in Brain Disorders

Dwivedi, D., Megha, K., Mishra, R., & Mandal, P. K. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03030-1 · Cited by 154 · see citing works

Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease

Plascencia-Villa, G., & Perry, G. (2023) · Antioxidants · doi:10.3390/antiox12081628 · Cited by 149 · see citing works

Glutathione elevation by γ‐glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain

Gururaj Joshi, A., Hardas, S. S., Rukhsana Sultana, A., Clair, D. K. S., Vore, M. E., & Butterfield, D. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21158 · Cited by 134 · see citing works

Efficacy of a Vitamin/Nutriceutical Formulation for Early-stage Alzheimer's Disease: A 1-year, Open-label Pilot Study With an 16-Month Caregiver Extension

Chan, A., Paskavitz, J., Remington, R., Rasmussen, S., & Shea, T. B. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317508325093 · Cited by 127 · see citing works

Spectroscopic and molecular docking studies on the interaction between N‐acetyl cysteine and bovine serum albumin

Jahanban‐Esfahlan, A., Panahi‐Azar, V., & Sajedi‐Amin, S. (2015) · Biopolymers · doi:10.1002/bip.22697 · Cited by 125 · see citing works

Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice

Clark, J., Clore, E. L., Zheng, K., Adame, A., Masliah, E., & Simon, D. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012333 · Cited by 118 · see citing works

Endometrial stromal cell ferroptosis promotes angiogenesis in endometriosis

Li, G., Lin, Y., Zhang, Y., Gu, N.-H., Yang, B. X., Shan, S., Liu, N., Ouyang, J., Yang, Y., Sun, F., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00821-z · Cited by 115 · see citing works

The effect of N-acetylcysteine (NAC) on human cognition – A systematic review

Skvarc, D., Dean, O. M., Byrne, L. K., Gray, L. J., Lane, S. E., Lewis, M., Fernandes, B. S., Berk, M., & Marriott, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.013 · Cited by 108 · see citing works

Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants

Domenico, F. D., Barone, E., Marzia Perluigi, A., & Butterfield, D. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.955853 · Cited by 102 · see citing works

Cognitive effects of adjunctive N-acetyl cysteine in psychosis

Rapado‐Castro, M., Dodd, S., Bush, A. I., Malhi, G. S., Skvarc, D., On, Z. X., Berk, M., & Dean, O. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716002932 · Cited by 103 · see citing works

Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models

Sonnen, J. A., Breitner, J. C. S., Lovell, M. A., Markesbery, W. R., Quinn, J. F., & Montine, T. J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.022 · Cited by 103 · see citing works

Treating Alzheimer's disease by targeting iron

Nikseresht, S., Bush, A. I., & Ayton, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14567 · Cited by 98 · see citing works

Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood–brain barrier: Protection by the antioxidant N-acetylcysteine

Erickson, M. A., Hansen, K. M., & Banks, W. A. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.07.003 · Cited by 100 · see citing works

Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease

Parachikova, A., Green, K. N., Hendrix, C., & LaFerla, F. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014015 · Cited by 87 · see citing works

Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets

Misiak, B., Beszłej, J. A., Kotowicz, K., Szewczuk-Bogusławska, M., Samochowiec, J., Kucharska–Mazur, J., & Frydecka, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.021 · Cited by 86 · see citing works

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

Bradlow, R. C. J., Berk, M., Kalivas, P. W., Back, S. E., & Kanaan, R. A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00907-3 · Cited by 87 · see citing works

Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model

Hsiao, Y., Kuo, J., Chen, S., & Gean, P. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.031 · Cited by 81 · see citing works

Effect of Chronic N-Acetyl Cysteine Administration on Oxidative Status in the Presence and Absence of Induced Oxidative Stress in Rat Striatum

Harvey, B. H., Joubert, C., du Preez, J. L., & Berk, M. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9466-y · Cited by 81 · see citing works

An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderly

McCarty, M. F., & DiNicolantonio, J. J. (2015) · AGE · doi:10.1007/s11357-015-9823-8 · Cited by 79 · see citing works

Synthesis, electrochemical and electrocatalytic behaviour of thiophene-appended cobalt, manganese and zinc phthalocyanine complexes

Obirai, J., & Nyokong, T. (2005) · Electrochimica Acta · doi:10.1016/j.electacta.2005.03.024 · Cited by 79 · see citing works

Erratum: Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines

Rose, S., Frye, R. E., Slattery, J., Wynne, R. A., Tippett, M., Melnyk, S., & James, S. J. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.29 · Cited by 78 · see citing works

Activated astrocytes: a therapeutic target in Alzheimer’s disease?

Fuller, S. L., Münch, G. W., & Steele, M. L. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.111 · Cited by 77 · see citing works

Spotlight on Ferroptosis: Iron-Dependent Cell Death in Alzheimer’s Disease

Ashraf, A., & So, P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00196 · Cited by 76 · see citing works

Spectrophotometric determination of glutathione and cysteine based on aggregation of colloidal gold nanoparticles

Hormozi-Nezhad, M. R., Seyedhosseini, E., & Robatjazi, H. (2012) · Scientia Iranica · doi:10.1016/j.scient.2012.04.018 · Cited by 76 · see citing works

Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation

Aaseth, J., Alexander, J., Bjørklund, G., Hestad, K. A., Dušek, P., Roos, P. M., & Alehagen, U. (2016) · BioMetals · doi:10.1007/s10534-016-9959-8 · Cited by 73 · see citing works

Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives

Salagre, E., Solé, B., Tomioka, Y., Fernandes, B. S., Hidalgo-Mazzei, D., Garriga, M., Jimenez, E., Sanchez-Moreno, J., Vieta, E., & Grande, I. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.034 · Cited by 71 · see citing works

Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention

Rossetti, A. C., Paladini, M. S., Riva, M. A., & Molteni, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107520 · Cited by 70 · see citing works

Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines

Rose, S., Frye, R. E., Slattery, J. M., Wynne, R. A., Tippett, M., Melnyk, S., & James, S. J. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.15 · Cited by 69 · see citing works

Antioxidants as a Potential Target against Inflammation and Oxidative Stress in Attention-Deficit/Hyperactivity Disorder

Álvarez‐Arellano, L., García, N. G., Salazar–García, M., & Corona, J. C. (2020) · Antioxidants · doi:10.3390/antiox9020176 · Cited by 68 · see citing works

Supplementation with γ-glutamylcysteine (γ-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD

Liu, Y., Chen, Z., Li, B., Yao, H., Zarka, M., Welch, J., Sachdev, P., Bridge, W., & Braidy, N. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104931 · Cited by 69 · see citing works

Astroglial activation: Current concepts and future directions

Edison, P. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13678 · Cited by 64 · see citing works

Alzheimer’s Disease and Antioxidant Therapy: How Long How Far?

Teixeira, J., Silva, T., Andrade, P. B., & Borges, F. (2013) · Current Medicinal Chemistry · doi:10.2174/1871523011320240001 · Cited by 59 · see citing works

Cognitive enhancers for facilitating drug cue extinction: Insights from animal models

Dhonnchadha, B. Á. N., & Kantak, K. M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.018 · Cited by 57 · see citing works

EVALUATION OF THE NEUROPROTECTIVE POTENTIAL OF N-ACETYLCYSTEINE FOR PREVENTION AND TREATMENT OF COGNITIVE AGING AND DEMENTIA

Hara, Y., Fillit, H. M., Dacks, P. A., & McKeehan, N. (2017) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2017.22 · Cited by 57 · see citing works

In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid β-peptide (1–42)-induced oxidative stress

Marzia Perluigi, A., Gururaj Joshi, A., Rukhsana Sultana, A., Calabrese, V., Marco, C. D., Coccia, R., & Butterfield, D. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.004 · Cited by 57 · see citing works

Improvement in muscular performance and decrease in tumor necrosis factor level in old age after antioxidant treatment

Hauer, K. A., Hildebrandt, W., Sehl, Y., Edler, L., Oster, P., & Dröge, W. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0406-7 · Cited by 57 · see citing works

Pharmacologic Agents Associated with a Preventive Effect on Alzheimer's Disease: A Review of the Epidemiologic Evidence

Veld, B. A. I. (2002) · Epidemiologic Reviews · doi:10.1093/epirev/mxf001 · Cited by 56 · see citing works

Therapeutic potential of sulfur-containing natural products in inflammatory diseases

Cao, X., Cao, L., Zhang, W., Lu, R., Bian, J., & Nie, X. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107687 · Cited by 54 · see citing works

The Potential of Ferroptosis-Targeting Therapies for Alzheimer’s Disease: From Mechanism to Transcriptomic Analysis

Majerníková, N., den Dunnen, W. F. A., & Dolga, A. M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.745046 · Cited by 55 · see citing works

Astrocyte glutathione maintains endothelial barrier stability

Huang, S.-F., Othman, A., Koshkin, A., Fischer, S., Fischer, D., Zamboni, N., Ono, K., Sawa, T., & Ogunshola, O. O. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101576 · Cited by 52 · see citing works

Elevated glutathione as a therapeutic strategy in Alzheimer's disease

Butterfield, D. A., Pocernich, C. B., & Drake, J. (2002) · Drug Development Research · doi:10.1002/ddr.10095 · Cited by 51 · see citing works

Is Antioxidant Therapy a Viable Alternative for Mild Cognitive Impairment? Examination of the Evidence

Ancelin, M., Christen, Y., & Ritchie, K. A. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000102567 · Cited by 49 · see citing works

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

Rossell, S. L., Francis, P. S., Galletly, C. A., Harris, A. W. F., Siskind, D. J., Berk, M., Bozaoglu, K., Dark, F. L., Dean, O. M., Liu, D., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1030-3 · Cited by 49 · see citing works

Intravenous administration of stable-labeled n-acetylcysteine demonstrates an indirect mechanism for boosting glutathione and improving redox status

Zhou, J., Coles, L. D., Kartha, R. V., Nash, N., Mishra, U., Lund, T. C., & Cloyd, J. C. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24482 · Cited by 47 · see citing works

The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer’s Disease: from the Perspective of Ferroptosis

Wu, L., Xian, X., Tan, Z., Dong, F., Xu, G., Zhang, M., & Zhang, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03245-7 · Cited by 50 · see citing works

Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47 · see citing works

Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer’s disease

Shen, Y., Zhang, G., Wei, C., Zhao, P., Wang, Y., Li, M., & Sun, L. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01343 · Cited by 44 · see citing works

d-Ribose-l-cysteine attenuates lipopolysaccharide-induced memory deficits through inhibition of oxidative stress, release of proinflammatory cytokines, and nuclear factor-kappa B expression in mice

Emokpae, O., Ben‐Azu, B., Ajayi, A. M., & Umukoro, S. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01805-0 · Cited by 41 · see citing works

Reactive Oxygen Species in Diabetes-induced Vascular Damage, Stroke, and Alzheimer's Disease

Muhammad, S., Bierhaus, A., & Schwaninger, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0982 · Cited by 42 · see citing works

N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases

Martı́nez, M. (2022) · Antioxidants · doi:10.3390/antiox11020416 · Cited by 44 · see citing works

Homocysteine and cognitive impairment; a case series in a General Practice setting

McCaddon, A. (2006) · Nutrition Journal · doi:10.1186/1475-2891-5-6 · Cited by 40 · see citing works

Potential neurotoxic inflammatory responses to Aβ vaccination in humans

Münch, G. W., & Robinson, S. R. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200091 · Cited by 40 · see citing works

N-Acetyl- l -Cysteine as Prophylaxis against Sulfur Mustard

Bobb, A. J., Arfsten, D. P., & Jederberg, W. W. (2005) · Military Medicine · doi:10.7205/milmed.170.1.52 · Cited by 39 · see citing works

The effects of N-Acetylcysteine on serum level of inflammatory biomarkers in adults. Findings from a systematic review and meta-analysis of randomized clinical trials

Askari, M., Faryabi, R., Mozaffari, H., & Mofrad, M. D. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155239 · Cited by 38 · see citing works

Clinical evidence of human pathogens implicated in Alzheimer’s disease pathology and the therapeutic efficacy of antimicrobials: an overview

Catumbela, C. S. G., Giridharan, V. V., Barichello, T., & Morales, R. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00369-7 · Cited by 37 · see citing works

N-Acetyl-l-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to Glutathione

Gleixner, A. M., Hutchison, D. F., Sannino, S., Bhatia, T. N., Leak, L. C., Flaherty, P. T., Wipf, P., Brodsky, J. L., & Leak, R. K. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.109926 · Cited by 36 · see citing works

Cadmium nitrate-induced neuronal apoptosis is protected by N-acetyl-l-cysteine via reducing reactive oxygen species generation and mitochondria dysfunction

Lee, C., Su, C.-H., Tsai, P., Yang, M., Ho, Y., Lee, S., Chen, C., Chen, W., Lin, M., Chen, C., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.054 · Cited by 37 · see citing works

Oral glutathione administration inhibits the oxidative stress and the inflammatory responses in AppNL−G-F/NL−G-F knock-in mice

Izumi, H., Sato, K., Kojima, K., Saito, T., Saido, T. C., & Fukunaga, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108026 · Cited by 37 · see citing works

Commonality of Ethanol and Nicotine Reinforcement and Relapse in Wistar‐Derived UChB Rats: Inhibition by N‐Acetylcysteine

Quintanilla, M. E., Morales, P., Ezquer, F. E., Ezquer, M., Herrera‐Marschitz, M., & Israel, Y. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13842 · Cited by 37 · see citing works

Do glutathione and copper interact to modify Alzheimer's disease pathogenesis?

Ho, T., Ahmadi, S., & Kerman, K. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.025 · Cited by 37 · see citing works

Effects of N-Acetyl-Cysteine on Neurocognition in a double-blind randomized placebo-controlled trial

Seidman, L. J., Conus, P., Fournier, M., Cleusix, M., Xin, L., Bauman, P., Ferrari, C., Cousins, A., Alameda, L., Gholam‐Rezaee, M., et al. (2016) · Infoscience (Ecole Polytechnique Fédérale de Lausanne)

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

(13684546), D., (13376715), J. S., (9884567), N. K., (13684549), L. D., Berk, M., (13088112), O. D., (13684552), C. S., & (13684555), R. F. (2025) · Figshare · Cited by 2 · see citing works

Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases

Tardiolo, G., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23123305 · Cited by 287 · see citing works

The effect of N-acetylcysteine (NAC) on human cognition – A systematic review

Skvarc, D., Dean, O. M., Byrne, L. K., Gray, L. J., Lane, S. E., Lewis, M., Fernandes, B. S., Berk, M., & Marriott, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.013 · Cited by 108 · see citing works

N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin

Costa, M. D., Bernardi, J., Costa, L., Fiuza, T. D. L., Brandão, R., Ribeiro, M. F., Amaral, J. D., Rodrigues, C. M. P., & Pereira, M. E. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.008 · Cited by 23 · see citing works